News Summary: Fast-growing salmon in FDA limbo

Published



STAYING AFLOAT: A Massachusetts biotech firm that was poised to become the first company to sell a genetically-modified fish says it may run out of money before regulators approve its fast-growing salmon.

FRANKENFISH: Aquabounty’s Atlantic salmon contains an extra hormone that makes it to grow twice as fast as a traditional salmon. Despite concerns from environmentalists, regulators said in 2010 that the fish appeared safe to eat.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.